AQR Arbitrage’s LumiraDx Limited Warrant LMDXW Stock Holding History

AQR Arbitrage’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-63,000	Closed	-$79K	–	1297
2021 Q3	$79K	Buy	+63,000	New	+$73.1K	﹤0.01%	849

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Integrity Capital Management (HK) Central, Hong Kong $64K AUM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

AQR Arbitrage's LMDXW Position: Q4 2021 in Review

AQR Arbitrage sold out of LumiraDx Limited Warrant (LMDXW) in Q4 2021, closing a stake of 63,000 shares — an estimated $79K sold.

AQR Arbitrage first reported a position in LMDXW in Q3 2021 and held it in 1 quarter. The position peaked at $79K in Q3 2021. 24 funds tracked by Wall St. Rank hold LMDXW as of Q4 2021.

AQR Arbitrage reported no remaining LumiraDx Limited Warrant position as of Q4 2021 after selling out during the quarter.
AQR Arbitrage sold 63,000 LumiraDx Limited Warrant shares in Q4 2021, an estimated $79K.
AQR Arbitrage first reported a position in LumiraDx Limited Warrant in Q3 2021 and held it in 1 quarter.
AQR Arbitrage's LumiraDx Limited Warrant position peaked at $79K in Q3 2021.
24 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q4 2021.

Based on AQR Arbitrage's 13F filing for Q4 2021, filed 14 Feb 2022.